Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDCD1 | Q15116 | 1/20 | 0.53 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 2/20 | 0.48 |
| ▸ | SLC1A5 | Q15758 | 1/20 | 0.46 |
| ▸ | RAB9A | P51151 | 2/20 | 0.46 |
| ▸ | NPC1 | O15118 | 1/20 | 0.46 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.46 |
| ▸ | EGFR | P00533 | 1/20 | 0.45 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.44 |
| ▸ | GSK3B | P49841 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | F2 | P00734 | 1/20 | 0.43 |
| ▸ | SCN1A | P35498 | 1/20 | 0.43 |
| ▸ | SCN2A | Q99250 | 1/20 | 0.43 |
| ▸ | SCN3A | Q9NY46 | 1/20 | 0.43 |
| ▸ | CDC25B | P30305 | 1/20 | 0.43 |
| ▸ | ATM | Q13315 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetic Acid SCHEMBL27750535 | 0.95 | SMN1; SMN2 (0.54) | PDCD1CD274SMN1; SMN2KDM4EMAPT | |
| SCHEMBL19506902 | 0.92 | PDCD1 (0.41) | PDCD1CD274SMN1; SMN2KDM4ESLC1A5 | |
| Benzoic Acid Vinyl Ester SCHEMBL28106984 | 0.88 | LMNA (0.56) | SMN1; SMN2MAPTLMNAF2HIF1A | |
| Benzoic Acid Vinyl Ester SCHEMBL14903 | 0.88 | LMNA (0.56) | SMN1; SMN2MAPTLMNAF2HIF1A | |
| SCHEMBL23082728 | 0.87 | PARP10 (0.57) | SMN1; SMN2KDM4EMAPTRAB9ANPC1 | |
| Benzoic Acid Vinyl Ester SCHEMBL6551336 | 0.86 | LMNA (0.54) | SMN1; SMN2MAPTLMNAF2HIF1A | |
| Benzoic Acid Vinyl Ester SCHEMBL6552669 | 0.86 | LMNA (0.54) | SMN1; SMN2MAPTLMNAF2HIF1A | |
| Benzoic Acid Vinyl Ester SCHEMBL5014943 | 0.86 | LMNA (0.54) | SMN1; SMN2MAPTLMNAF2HIF1A | |
| Benzoic Acid Vinyl Ester SCHEMBL6551316 | 0.86 | LMNA (0.54) | SMN1; SMN2MAPTLMNAF2HIF1A | |
| Benzoic Acid Vinyl Ester SCHEMBL2909961 | 0.86 | LMNA (0.54) | SMN1; SMN2MAPTLMNAF2HIF1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 60 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4693286-A1 | PHOTOSENSITIVE COMPOSITION FOR HOLOGRAM RECORDING, HOLOGRAM RECORDING MEDIUM, POLYMER, LARGE CAPACITY MEMORY, OPTICAL ELEMENT, AR LIGHT GUIDE PLATE, AND AR GLASSES | Mitsubishi Chemical Corporation (JP) | 2026-02-11 | — | — | EP | disclosed |
| EP-4692042-A1 | COMPOUND, POLYMERIZABLE COMPOSITION, HOLOGRAM RECORDING MEDIUM, POLYMER, OPTICAL MATERIAL, AND OPTICAL COMPONENT | Mitsubishi Chemical Corporation (JP) | 2026-02-11 | — | — | EP | disclosed |
| US-20260028312-A1 | COMPOUND, POLYMERIZABLE COMPOSITION, HOLOGRAM RECORDING MEDIUM, POLYMER, OPTICAL MATERIAL, AND OPTICAL COMPONENT | MITSUBISHI CHEMICAL CORPORATION (JP) | 2026-01-29 | — | — | US | disclosed |
| US-20260023321-A1 | PHOTOSENSITIVE COMPOSITION FOR HOLOGRAM RECORDING, HOLOGRAM RECORDING MEDIUM, POLYMER, LARGE CAPACITY MEMORY, OPTICAL ELEMENT, AR LIGHT GUIDE PLATE, AND AR GLASSES | MITSUBISHI CHEMICAL CORPORATION (JP) | 2026-01-22 | — | — | US | disclosed |
| EP-4606785-A1 | COMPOUND, POLYMERIZABLE COMPOSITION, POLYMER, HOLOGRAM RECORDING MEDIUM, OPTICAL MATERIAL, AND OPTICAL COMPONENT | Mitsubishi Chemical Corporation (JP) | 2025-08-27 | — | — | EP | disclosed |
| US-20250206731-A1 | COMPOUND, POLYMERIZABLE COMPOSITION, POLYMER, HOLOGRAPHIC RECORDING MEDIUM, OPTICAL MATERIAL, AND OPTICAL COMPONENT | MITSUBISHI CHEMICAL CORPORATION (JP) | 2025-06-26 | — | — | US | disclosed |
| CN-119998258-A | Compound, polymerizable composition, polymer, hologram recording medium, optical material, and optical member | 三菱化学株式会社 | 2025-05-13 | — | — | CN | disclosed |
| EP-4549430-A1 | COMPOUND, POLYMERIZABLE COMPOSITION, POLYMER, HOLOGRAPHIC RECORDING MEDIUM, OPTICAL MATERIAL AND OPTICAL COMPONENT | Mitsubishi Chemical Corporation (JP) | 2025-05-07 | — | — | EP | disclosed |
| US-20250122178-A1 | COMPOUND, POLYMERIZABLE COMPOSITION, POLYMER, HOLOGRAPHIC RECORDING MEDIUM, OPTICAL MATERIAL, AND OPTICAL COMPONENT | MITSUBISHI CHEMICAL CORPORATION (JP) | 2025-04-17 | — | — | US | disclosed |
| CN-119403785-A | Compound, polymerizable composition, polymer, hologram image recording medium, optical material, and optical component | 三菱化学株式会社 | 2025-02-07 | — | — | CN | disclosed |
| CN-1768115-A | Polylactic acid resin composition and preparation method thereof and poly(lactic acid) biaxially oriented film and by its moulding product that constitute | TORAY INDUSTRIES (JP) | 2006-05-03 | — | — | CN | disclosed |
| EP-1609819-A1 | POLYLACTIC ACID RESIN COMPOSITION, PROCESS FOR PRODUCING THE SAME, BIAXIALLY STRETCHED POLYLACTIC ACID FILM, AND MOLDED ARTICLES THEREOF | TORAY INDUSTRIES, INC. (JP) | 2005-12-28 | — | — | EP | disclosed |
| EP-1478403-A1 | RESPONSIVE MICROGEL AND METHODS RELATED THERETO | SUPRATEK PHARMA, INC. (CA) | 2004-11-24 | — | — | EP | disclosed |
| US-20030152623-A1 | Responsive microgel and methods related thereto | SUPRATEK PHARMA INC. (CA) | 2003-08-14 | — | — | US | disclosed |
| WO-2003063909-A1 | RESPONSIVE MICROGEL AND METHODS RELATED THERETO | SUPRATEK PHARMA INC. (US) | 2003-08-07 | — | — | WO | disclosed |
| EP-0910351-A1 | PARTICLES COMPRISING AMPHIPHILIC COPOLYMERS, HAVING A CROSS-LINKED SHELL DOMAIN AND AN INTERIOR CORE DOMAIN, USEFUL FOR PHARMACEUTICAL AND OTHER APPLICATIONS | G.D. Searle & Co. (US) | 1999-04-28 | — | — | EP | disclosed |
| EP-0907666-A1 | PARTICLES COMPRISING AMPHIPHILIC COPOLYMERS, HAVING A CROSS-LINKED SHELL DOMAIN AND AN INTERIOR CORE DOMAIN, USEFUL FOR PHARMACEUTICAL AND OTHER APPLICATIONS | G.D. Searle & Co. (US) | 1999-04-14 | — | — | EP | disclosed |
| WO-1997049736-A2 | PARTICLES COMPRISING AMPHIPHILIC COPOLYMERS, HAVING A CROSS-LINKED SHELL DOMAIN AND AN INTERIOR CORE DOMAIN, USEFUL FOR PHARMACEUTICAL AND OTHER APPLICATIONS | G.D. SEARLE AND CO. (US) | 1997-12-31 | — | — | WO | disclosed |
| WO-1997049387-A1 | PARTICLES COMPRISING AMPHIPHILIC COPOLYMERS, HAVING A CROSS-LINKED SHELL DOMAIN AND AN INTERIOR CORE DOMAIN, USEFUL FOR PHARMACEUTICAL AND OTHER APPLICATIONS | G.D. SEARLE AND CO. (US) | 1997-12-31 | — | — | WO | disclosed |
| US-5294484-A | Multilayer element | SONY CORPORATION (JP) | 1994-03-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260028312-A1 | COMPOUND, POLYMERIZABLE COMPOSITION, HOLOGRAM RECORDING MEDIUM, POLYMER, OPTICAL MATERIAL, AND OPTICAL COMPONENT | CHRM1, CHRM2, NOX1 | PDCD1 3528/4885CD274 2119/4885SMN1; SMN2 615/4885 |
| US-20250206731-A1 | COMPOUND, POLYMERIZABLE COMPOSITION, POLYMER, HOLOGRAPHIC RECORDING MEDIUM, OPTICAL MATERIAL, AND OPTICAL COMPONENT | H1-0, H1-3, H1-2 | PDCD1 4772/4885CD274 3974/4885SMN1; SMN2 2247/4885 |
| US-20250122178-A1 | COMPOUND, POLYMERIZABLE COMPOSITION, POLYMER, HOLOGRAPHIC RECORDING MEDIUM, OPTICAL MATERIAL, AND OPTICAL COMPONENT | H1-0, H1-2, CCNB2 | PDCD1 3899/4885CD274 2374/4885SMN1; SMN2 1478/4885 |
| US-20260023321-A1 | PHOTOSENSITIVE COMPOSITION FOR HOLOGRAM RECORDING, HOLOGRAM RECORDING MEDIUM, POLYMER, LARGE CAPACITY MEMORY, OPTICAL ELEMENT, AR LIGHT GUIDE PLATE, AND AR GLASSES | RAD51, NAP1L1, RPA1 | PDCD1 3226/4885CD274 1018/4885SMN1; SMN2 437/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.